FAS and Alzheimer disease: Fas −1377 genotypes showed significant effect modification of pulmonary AD risk by FasL −844 genotype by test of the interaction term adjusting for age, gender, FasL −844, and Fas −1377 SNP (aOR = 1.531, 95 % CI = 1.066–2.201, P = 0.021).